EQL Pharma recruits Carl Lindgren as Chief Business Development Officer
EQL has recruited Carl Lindgren as Chief Business Development Officer (CBDO). Carl replaces Alexander Brising, who was responsible for Business Development and built the company's pipeline since 2016, but now changes position within EQL to Chief Commercial Officer (CCO) with responsibility for the company's sales and marketing.Carl Lindgren has more than 30 years of experience in the pharmaceutical industry and comes most recently from a role as Vice President M&A/BD at Karo Healthcare (formerly Karo Pharma), which during Carl's time has grown from approx. SEK 350m to approx. 4.5bn in